TranS1 is a medical technology company that has developed an innovative approach to spinal surgery. We were invited to assist with the development and design of a presentation to institutional investors when TransS1 sought investment for their IPO on NASDAQ. We worked closely with the CEO, CFO and two joint book-runners to create an informative exposition of complex medical procedures for the layman and highlight the potential of the TranS1 product. Animations and multimedia elements were used to emphasise the salient facts to allow investors to make informed decisions.